Summary
A bioRxiv preprint describes a hydrogel made from the extracellular matrix produced by Acinetobacter baylyi ADP1. The material can be modified for light-triggered crosslinking and is reported as porous, injectable, cytocompatible and suitable for 3D bioprinting.
A team led by researchers at Tampere University has reported a hydrogel made from the extracellular matrix produced by the bacterium Acinetobacter baylyi ADP1. The bioRxiv preprint, posted on September 14, 2026, describes the material as porous, cytocompatible, injectable and suitable for 3D bioprinting.
The researchers cultivated the bacterium for three days and used a simple extraction method to obtain its extracellular polymeric substances, or EPS. These substances form a matrix outside bacterial cells and contain both polysaccharides and proteins. The extracted material was then chemically modified so it could be photocrosslinked with red or blue light.
Because this work is reported in a preprint, the findings are available before peer review. The material is being presented as a platform for biofabrication rather than as a tested medical treatment.
How the bacterial material becomes a hydrogel
Hydrogels are water-rich polymer networks that can provide a soft, three-dimensional environment for cells and biological materials. In tissue engineering, their composition and structure affect properties such as how cells interact with the material, how nutrients move through it and how the material holds its shape.
The paper’s approach begins with a naturally produced mixture rather than a single purified polymer. The authors describe the EPS from A. baylyi ADP1 as a multicomponent matrix containing polysaccharides and proteins. According to the preprint, this biological complexity could offer more biochemical and mechanical flexibility than formulations built around only one component.
The extracted hydrogel was methacrylated. Methacrylation adds light-reactive chemical groups to a material; when the modified hydrogel is illuminated under suitable conditions, the groups can form links between polymer chains. This process, called photocrosslinking, converts the material into a more stable network and allows gelation to be controlled with light.
The reported formulation can be crosslinked using either red or blue light. It also undergoes rapid gelation for in situ crosslinking, meaning that a liquid or injectable formulation can be placed before being solidified at the intended location. That combination may be useful in workflows where a material must be shaped, deposited or injected before it reaches its final form.
Potential for biofabrication
The preprint describes the hydrogel as 3D-bioprintable, injectable and cytocompatible, bringing together properties that are relevant to tissue-engineering materials. A printable hydrogel must flow through a nozzle and then retain enough structure after deposition. An injectable formulation similarly needs to move under pressure while allowing subsequent gel formation. The reported light-triggered chemistry provides one possible way to control that transition.
The multicomponent origin of the material is the central technical feature. Natural extracellular matrices contain combinations of structural and signalling-related molecules, while many synthetic hydrogel systems use simpler compositions. A bacterial EPS matrix could therefore provide a biologically derived starting point for designing materials with several functional components in one formulation. This is a potential advantage of the strategy, not evidence of a particular clinical benefit.
The supplied abstract does not identify a specific tissue-engineering application or describe in vivo testing. It also does not provide the cell model, sample size, mechanical measurements, printing parameters or duration of the cytocompatibility assessment. Those details will be important for judging how the material compares with existing bioinks and whether it can progress beyond laboratory biofabrication.
The authors state that a patent application related to the work has been filed. The study was conducted by researchers primarily affiliated with Tampere University, with contributors from the University of California, Berkeley, and the University of Helsinki.